Viewing Study NCT02404051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-06-17 @ 8:09 AM
Study NCT ID: NCT02404051
Status: UNKNOWN
Last Update Posted: 2016-06-15
First Post: 2015-01-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
Sponsor: Consorzio Oncotech
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
None Breast Cancer View
None Hormone Receptor Positive Tumor View
None Human Epidermal Growth Factor 2 Negative Carcinoma of Breast View
None Locally Advanced Malignant Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast cancer View
None HER2Negative View
None hormone receptor positive (HR+) View
None Metastatic View
None Locally Advanced View
None fulvestrant View
None everolimus View
None exemestane View